These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7548698)

  • 21. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential analysis of censored survival data from three treatment groups.
    Betensky RA
    Biometrics; 1997 Sep; 53(3):807-22. PubMed ID: 9333347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exact, distribution free confidence intervals for late effects in censored matched pairs.
    Daniel SR
    Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sliced inverse regression with regularizations.
    Li L; Yin X
    Biometrics; 2008 Mar; 64(1):124-31. PubMed ID: 17651455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renovating interval-censored responses.
    Smith PJ
    Lifetime Data Anal; 1996; 2(1):51-61. PubMed ID: 9384648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.
    Datta S; Le-Rademacher J; Datta S
    Biometrics; 2007 Mar; 63(1):259-71. PubMed ID: 17447952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonparametric estimation of the bivariate recurrence time distribution.
    Huang CY; Wang MC
    Biometrics; 2005 Jun; 61(2):392-402. PubMed ID: 16011685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of the GSK method to the determination of minimum sample sizes.
    Rochon J
    Biometrics; 1989 Mar; 45(1):193-205. PubMed ID: 2655729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantel-Haenszel-type tests for testing equivalence or more than equivalence in comparative clinical trials.
    Yanagawa T; Tango T; Hiejima Y
    Biometrics; 1994 Sep; 50(3):859-64. PubMed ID: 7981407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes.
    Ji Y; Bekele BN
    Biometrics; 2009 Sep; 65(3):876-84. PubMed ID: 19173694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of times to repeated events in two-arm randomized trials with noncompliance and dependent censoring.
    Matsui S
    Biometrics; 2004 Dec; 60(4):965-76. PubMed ID: 15606417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An approximate likelihood procedure for censored data.
    Oakes D
    Biometrics; 1986 Mar; 42(1):177-82. PubMed ID: 3719053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian error-in-variable survival model for the analysis of GeneChip arrays.
    Tadesse MG; Ibrahim JG; Gentleman R; Chiaretti S; Ritz J; Foa R
    Biometrics; 2005 Jun; 61(2):488-97. PubMed ID: 16011696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A permutational step-up method of testing multiple outcomes.
    Troendle JF
    Biometrics; 1996 Sep; 52(3):846-59. PubMed ID: 8805759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
    Emerson SS
    Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimization method for balancing continuous prognostic variables between treatment and control groups using Kullback-Leibler divergence.
    Endo A; Nagatani F; Hamada C; Yoshimura I
    Contemp Clin Trials; 2006 Oct; 27(5):420-31. PubMed ID: 16807130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling progression of CD4-lymphocyte count and its relationship to survival time.
    De Gruttola V; Tu XM
    Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LSS: an S-Plus/R program for the accelerated failure time model to right censored data based on least-squares principle.
    Huang L; Jin Z
    Comput Methods Programs Biomed; 2007 Apr; 86(1):45-50. PubMed ID: 17250925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.